Analyst Price Targets — KZR
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 17, 2025 10:56 am | — | Wells Fargo | $5.00 | $4.17 | TheFly | Kezar Life Sciences price target lowered to $5 from $7 at Wells Fargo |
| October 17, 2025 8:50 am | Maury Raycroft | Jefferies | $7.00 | $4.17 | TheFly | Kezar Life Sciences downgraded to Hold from Buy at Jefferies |
| December 19, 2024 12:20 pm | Derek Archila | Wells Fargo | $9.00 | $6.26 | TheFly | Kezar Life Sciences price target lowered to $9 from $11 at Wells Fargo |
| August 12, 2022 7:02 am | — | H.C. Wainwright | $21.00 | $9.76 | Benzinga | HC Wainwright & Co. Maintains Buy on Kezar Life Sciences, Raises Price Target to $21 |
| May 4, 2022 8:34 am | — | Wells Fargo | $14.00 | $7.94 | Benzinga | Wells Fargo Maintains Overweight on Kezar Life Sciences, Lowers Price Target to $14 |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
No recent news available for KZR.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KZR.
U.S. House Trading
No House trades found for KZR.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
